Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo - Wikidata - wikimedia - TriplyDB

Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo

Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo

http://www.wikidata.org/entity/Q30316789

about

The multifaceted role of lysine acetylation in cancer: prognostic biomarker and therapeutic target Successful strategies in the discovery of small-molecule epigenetic modulators with anticancer potential.A novel nuclear Src and p300 signaling axis controls migratory and invasive behavior in pancreatic cancer.Histone acetyl transferase GCN5 promotes human hepatocellular carcinoma progression by enhancing AIB1 expression Modulation of p300/CBP Acetylation of Nucleosomes by Bromodomain Ligand I-CBP112.Regulation, Function, and Detection of Protein Acetylation in Bacteria.CREB-binding protein regulates lung cancer growth by targeting MAPK and CPSF4 signaling pathway.Selectivity on-target of bromodomain chemical probes by structure-guided medicinal chemistry and chemical biology.MYC-Master Regulator of the Cancer Epigenome and Transcriptome.Differential Effects of Histone Acetyltransferase GCN5 or PCAF Knockdown on Urothelial Carcinoma Cells Chromatin remodeling system p300-HDAC2-Sin3A is involved in Arginine Starvation-Induced HIF-1α Degradation at the ASS1 promoter for ASS1 Derepression.Epigenetic Mechanisms of Tamoxifen Resistance in Luminal Breast Cancer.The role of epigenomics in personalized medicine.Potential anti-genotoxic effect of sodium butyrate to modulate induction of DNA damage by tamoxifen citrate in rat bone marrow cells.Targeting of epigenetic regulators in neuroblastoma.Reactivation of endogenous retroviral elements via treatment with DNMT- and HDAC-inhibitors.KAT3B-p300 and H3AcK18/H3AcK14 levels are prognostic markers for kidney ccRCC tumor aggressiveness and target of KAT inhibitor CPTH2.Methylation of DNA and chromatin as a mechanism of oncogenesis and therapeutic target in neuroblastoma.

P2860

Q26744292-D647EC91-724F-45F4-8F39-3CC9C45BC37D Q35824823-D639A134-8C27-45C6-B4FC-EB0EF0817B5A Q35875878-9DD02583-4536-4631-B3D1-4A5D21C6F024 Q37144686-1E7397F9-0D65-46D5-90D5-75A1A32257C1 Q37223691-54BD7E7D-22D2-4AB5-B3D9-EFEEBC9C24D4 Q38691364-BB218678-A929-4B9B-8495-8F79720ADB0E Q38815116-519CC396-CF61-4011-9F44-D5E57B72320E Q38837561-9133E18F-9017-4730-8F15-59320B29FFF9 Q39306981-3C41FB56-D918-4CB5-B04B-28A6E1D11BA4 Q41182202-C5720DBC-A197-45F1-824F-E3DE82300878 Q41534994-F000E7FD-EC42-4BE1-8B93-08C7CC65D499 Q42367979-D3CAA608-5859-41C3-83C3-6EC4A5EFEE2F Q49584264-C2D661A0-04F7-4DCE-BDCC-BB50CC3C84D5 Q50056574-2EF9FA09-5848-4B96-A8DE-6A378CFBD6F2 Q52560224-60A7F28D-9D8A-4E27-BF8E-31240FDFB27E Q52596812-701679F6-6A80-4107-85B1-1D62E346A29F Q52597611-C506D21E-3357-4057-A4AB-611175A13C86 Q55267254-5CC9FD71-FCDE-4389-8E12-BB252D11D398

P2860

Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo

http://www.wikidata.org/entity/Q30316789

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo

@ast

Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo

@en

type

label

Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo

@ast

Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo

@en

prefLabel

Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo

@ast

Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo

@en

P1433

Q30316789-8B8374A4-81FE-4E15-BF42-19B55ED7297A

P1476

Q30316789-D9E42C78-9B62-4D65-ACD5-FE4D4EA60675

P2093

Q30316789-02BF9258-75A0-4FE9-B59B-E25C3B18D003

Q30316789-12718DE0-C1C4-43EB-A006-2D95C22CADB9

Q30316789-12DB9DA7-0431-4563-B114-77CD5056B5E1

Q30316789-4F430191-A7C2-49AC-835B-BC0B74F281AE

Q30316789-BE452876-ADF9-4259-88D0-6E4E583F9FFA

Q30316789-C8C4EBCA-26EE-4527-A184-E8499EBBD7B2

Q30316789-E35EB941-41A0-4DA2-ABFE-212031DF156C

Q30316789-E8CCAF75-2A86-4747-8197-C01FEC836998

Q30316789-F7D9BCB2-7867-4FD8-808E-FFBD61FA4583

P2860

Q30316789-034E22E2-BB12-4EC1-9B1D-3024F286D8BB

Q30316789-0402FF1A-5F6B-428D-84D1-077286A21712

Q30316789-045C9194-04C0-4E4F-9E29-20BD285C642C

Q30316789-0554212A-0DDB-4948-B4EA-010573C96F50

Q30316789-08BD2B5F-125B-43CA-AA8C-A7FF4F05ADE3

Q30316789-0AD50E16-DC88-4C1F-8E97-6B5D0DDAD548

Q30316789-0D5D28D5-146F-48FC-A78E-6B59994ACD97

Q30316789-16D52B1A-10BD-4D6C-B4CC-E8396C170671

Q30316789-1A1EA7DA-0A39-4134-8634-44614AEB05D1

Q30316789-2C1C3610-0646-4542-8B97-06D76295DC98

P2888

Q30316789-55662F3A-67B6-47F4-B891-23166DD73636

P304

Q30316789-B71F4E6B-226E-4EB7-83AF-F1C1178F7BD8

P31

Q30316789-DA695B9D-4A9D-48F9-98F7-835347F564F9

P356

Q30316789-FFC1BC6A-712B-41B8-AE68-0121EF3D1137

P478

Q30316789-EC9FB352-A123-44DE-A107-A86D0D517251

P50

Q30316789-2BBBE12A-2EEE-46BB-8C4F-7F0176A6355B

Q30316789-33F41381-6C77-4620-BFBF-5DBEA49FDC34

Q30316789-7D8E5388-5BFB-4738-9D17-5FAB885634ED

P577

Q30316789-8936080A-BF5E-4B35-89AD-3ECC4A7C9EEE

P5875

Q30316789-BA1784C1-A35B-4FC1-94E2-1F683A3844B8

P6179

Q30316789-1ACCFA98-F751-4DDA-8975-864E3A87C239

P698

Q30316789-E107BAD3-73FA-4F08-AC13-4CE6E1408FF8

P932

Q30316789-0E47DFB3-B591-4CA7-BA9F-21F671A59580

P356

P1433

P1476

Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo

@en

P2093

A Gründer

http://www.w3.org/2001/XMLSchema#string

F Colland

http://www.w3.org/2001/XMLSchema#string

H L Pahl

http://www.w3.org/2001/XMLSchema#string

I Fichtner

http://www.w3.org/2001/XMLSchema#string

J M Gajer

http://www.w3.org/2001/XMLSchema#string

K Keller

http://www.w3.org/2001/XMLSchema#string

M Gothwal

http://www.w3.org/2001/XMLSchema#string

S D Furdas

http://www.w3.org/2001/XMLSchema#string

U Heinicke

http://www.w3.org/2001/XMLSchema#string

P2860

Acetylation of histones and transcription-related factors

New and emerging HDAC inhibitors for cancer treatment

The structural basis of protein acetylation by the p300/CBP transcriptional coactivator

Lysine acetylation targets protein complexes and co-regulates major cellular functions

The language of covalent histone modifications

Histone acetyltransferases: function, structure, and catalysis

Epigenetic changes modulate schistosome egg formation and are a novel target for reducing transmission of schistosomiasis

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

Epigenetics in cancer

New colorimetric cytotoxicity assay for anticancer-drug screening

P2888

P304

e137

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ONCSIS.2014.51

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272096041

http://www.w3.org/2001/XMLSchema#string

P6179

1004757525

http://www.w3.org/2001/XMLSchema#string

P698

25664930

http://www.w3.org/2001/XMLSchema#string

P932

4338425

http://www.w3.org/2001/XMLSchema#string